Avenue Therapeutics Inc (ATXI)
3.71
-0.09
(-2.37%)
USD |
NASDAQ |
May 22, 16:00
3.74
+0.03
(+0.81%)
After-Hours: 20:00
Avenue Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | -1.00M |
| September 30, 2020 | 4.00M |
| June 30, 2020 | 4.00M |
| March 31, 2020 | -1.00M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -5.00M |
| June 30, 2019 | -5.00M |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 10.00M |
| September 30, 2018 | 10.00M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -10.00M |
| September 30, 2017 | -10.00M |
| June 30, 2017 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.00M
Minimum
Jun 2019
4.00M
Maximum
Jun 2020
-0.5714M
Average
-1.00M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
| Fortress Biotech Inc | 2.897M |
| SINTX Technologies Inc | -0.438M |
| Deciphera Pharmaceuticals Inc | 110.59M |
| Flora Growth Corp | -0.22M |
| NovaBay Pharmaceuticals Inc | 1.062M |